Compounds > niacinamide

niacinamide and tretazicar

niacinamide has been researched along with tretazicar in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boland, MP; Davies, LC; Friedlos, F; Jarman, M; Knox, RJ1
Friedlos, F; Knox, RJ1
Abrahamson, JA; Biggs, PJ; Friedlos, F; Knox, RJ1
Chen, S; Deng, PS; Jaiswal, AK; Joseph, P; Knox, R; Sun, XZ; Wu, K; Zhang, D1
Burke, PJ; Chen, S; Hobbs, SM; Jenkins, TC; Knox, RJ; Melton, RG1

Other Studies

5 other study(ies) available for niacinamide and tretazicar

ArticleYear
Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
    Biochemical pharmacology, 1992, Jul-07, Volume: 44, Issue:1

    Topics: Animals; Aziridines; Carcinoma 256, Walker; Coenzymes; Kinetics; NAD(P)H Dehydrogenase (Quinone); NADP; Niacinamide; Nicotinamide Mononucleotide; Oxidation-Reduction; Pyridinium Compounds; Rats; Structure-Activity Relationship; Vitamin K

1992
Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system.
    Biochemical pharmacology, 1992, Aug-18, Volume: 44, Issue:4

    Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Blood; Blood Coagulation; Cattle; Dihydrolipoamide Dehydrogenase; Horses; Humans; Hydrolysis; Lactates; NAD; NADP; Niacinamide; Oxidation-Reduction; Prodrugs; Tumor Cells, Cultured

1992
Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity.
    Biochemical pharmacology, 1992, Nov-03, Volume: 44, Issue:9

    Topics: Antineoplastic Agents; Aziridines; DNA, Neoplasm; Drug Synergism; Humans; Intracellular Fluid; Kinetics; NAD; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Pyridinium Compounds; Ribonucleosides; Stimulation, Chemical; Tumor Cells, Cultured

1992
Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Archives of biochemistry and biophysics, 1997, Nov-15, Volume: 347, Issue:2

    Topics: Amino Acid Sequence; Aziridines; Escherichia coli; Humans; Molecular Sequence Data; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Oxidation-Reduction; Recombinant Fusion Proteins; Recombinant Proteins; Sequence Homology, Amino Acid

1997
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Cancer research, 2000, Aug-01, Volume: 60, Issue:15

    Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cell Line; Cricetinae; Cricetulus; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Isoenzymes; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Prodrugs; Pyridinium Compounds; Substrate Specificity; Transfection; Tumor Cells, Cultured

2000